These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 28279502
1. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity. López P, Rodríguez-Carrio J, Martínez-Zapico A, Caminal-Montero L, Suárez A. Int J Cardiol; 2017 Jun 01; 236():138-144. PubMed ID: 28279502 [Abstract] [Full Text] [Related]
2. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. Burbano C, Villar-Vesga J, Orejuela J, Muñoz C, Vanegas A, Vásquez G, Rojas M, Castaño D. Front Immunol; 2018 Jun 01; 9():322. PubMed ID: 29545790 [Abstract] [Full Text] [Related]
3. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH. Arthritis Rheum; 2011 Oct 01; 63(10):3067-77. PubMed ID: 21702008 [Abstract] [Full Text] [Related]
8. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E. Sci Rep; 2016 Oct 25; 6():36025. PubMed ID: 27777414 [Abstract] [Full Text] [Related]
9. Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes. Winberg LK, Jacobsen S, Nielsen CH. Arthritis Res Ther; 2017 Oct 17; 19(1):230. PubMed ID: 29041967 [Abstract] [Full Text] [Related]
10. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Patiño-Trives AM, Pérez-Sánchez C, Pérez-Sánchez L, Luque-Tévar M, Ábalos-Aguilera MC, Alcaide-Ruggiero L, Arias-de la Rosa I, Román-Rodríguez C, Seguí P, Espinosa M, Font P, Barbarroja N, Escudero-Contreras A, Antonio González-Reyes J, Manuel Villalba J, Collantes-Estévez E, Aguirre-Zamorano MÁ, López-Pedrera C. Arterioscler Thromb Vasc Biol; 2021 Sep 17; 41(9):2417-2430. PubMed ID: 34320837 [Abstract] [Full Text] [Related]
12. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes. López P, Scheel-Toellner D, Rodríguez-Carrio J, Caminal-Montero L, Gordon C, Suárez A. Rheumatology (Oxford); 2014 Dec 17; 53(12):2249-58. PubMed ID: 24942493 [Abstract] [Full Text] [Related]
13. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases. Burbano C, Villar-Vesga J, Vásquez G, Muñoz-Vahos C, Rojas M, Castaño D. Front Immunol; 2019 Dec 17; 10():2058. PubMed ID: 31555283 [Abstract] [Full Text] [Related]
14. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report. Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R. Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917 [Abstract] [Full Text] [Related]
15. Plasma microparticles from patients with systemic lupus erythematosus modulate the content of miRNAs in U937 cells. Carmona-Pérez L, Rojas M, Muñoz-Vahos C, Vanegas-García A, Vásquez G. Immunology; 2021 Oct 03; 164(2):253-265. PubMed ID: 34003488 [Abstract] [Full Text] [Related]
16. Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus. Zhou H, Hu B, Huang N, Mo X, Li W, Zhang B, Wei B, Gao M, Wang Y, Liu X, Liao J. Clin Rheumatol; 2018 Sep 03; 37(9):2405-2413. PubMed ID: 29785672 [Abstract] [Full Text] [Related]
17. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, Rosado S, Andreu JL, Vargas JA. Cytometry B Clin Cytom; 2009 Jul 03; 76(4):261-70. PubMed ID: 19199277 [Abstract] [Full Text] [Related]
18. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer. Iversen LV, Ostergaard O, Nielsen CT, Jacobsen S, Heegaard NH. J Immunol Methods; 2013 Feb 28; 388(1-2):49-59. PubMed ID: 23246793 [Abstract] [Full Text] [Related]
19. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Stone RC, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P, Eloranta ML, Rönnblom L, Barnes BJ. Arthritis Rheum; 2012 Mar 28; 64(3):788-98. PubMed ID: 21968701 [Abstract] [Full Text] [Related]
20. [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus]. Romanova NV, Shilkina NP. Ter Arkh; 2009 Mar 28; 81(4):40-3. PubMed ID: 19514420 [Abstract] [Full Text] [Related] Page: [Next] [New Search]